marijuana stocks news

Advantis Corp. Receiving Larger, Ongoing Amstercan Orders

The strategy Advantis employs to build consistent revenue streams, using Amstercan as its anchor offering, is proving successful. “In the beginning, everyone was intrigued and ordered small amounts to test before they ordered larger quantities,” Advantis CEO, Christopher Swartz, stated. “Now that Amstercan is becoming more well known as being synonymous with the highest quality product, we are receiving large orders right off the bat; and those that did test orders are all ordering larger and larger quantities.” Advantis picked up Chateau Cannabis Co. as a client in March, and their second order for Amstercans was more than triple their first order. Nature’s Top Shelf ordered over 5,000 Amstercans for their first order, and are requesting this amount on a monthly basis. “Building a consistent Amstercan client base and supplying superior service to them is paramount to Advantis’ success,” Swartz said. “Amstercans are the key that opens the door to the litany of new products we are able to introduce through our client and partner pipeline. The ongoing revenue from from our loyal Amstercan clients supply the necessary cash flow to support our ongoing efforts to expand the Advantis footprint.” Swartz asserted that several new potential Amstercan clients will soon be added, as soon as Advantis receives the higher volume packaging machine.

Revenue is consistently increasing at Advantis, and Swartz related his plan for managing the increasing volume of business. “Obviously, we are increasing revenue, but now I see profit in sight,” Swartz explained. “To get there, we are reducing our costs by ordering larger quantities of materials, and the new canning machine will cut more costs by allowing us to automate more processes. We should receive it this month.” Advantis has been supplying its existing Amstercan clients and partners with its entire product lineup, which has also been adding to Advantis’ bottom line. “We are in a great place right now. We are consistently growing our client base, introducing new products, and more importantly, word is spreading throughout the cultivator community that Amstercan is a great way to preserve and deliver their highest quality products. Our canning business is literally growing exponentially, and I see all of our products participating in that success.” Swartz concluded his comments by saying he was excited to share news of first quarter revenue, which will be reported in the next 7 days.

Links to Advantis websites can be found at advantiscorp.com, rosin6.com, elixicure.com, and amstercan.com

Follow on Social Media Facebook Instagram

Forward Looking Statements: This news release contains forward-looking statements made by ADVANTIS CORPORATION. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward- looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward- looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under eitherAct.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

GT Biopharma Inc. (GTBP) Starts FDA Phase 1 Clinical Trial for Myasthenia Gravis Autoimmune Muscular Disease

GT Biopharma, Inc. Starts FDA Phase 1 Clinical Trial for Myasthenia Gravis…

$CANL is Meeting the Demand in Colorado

CannLabs Expands Testing Capacity To Meet Additional Colorado Marijuana Testing Mandates And…

$BLPG for Protection and Transportation Colorado’s Largest Marijuana Dispensary

Colorado’s Largest Marijuana Dispensary Brand Chooses Blue Line Protection Group for Protection…

Green Thumb Industries Inc. (GTBIF) Publishes Inaugural Social Impact Report

Green Thumb Industries Publishes Inaugural Social Impact Report Green Thumb Industries Inc.…